Key Developments: Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

75.98USD
30 Sep 2014
Price Change (% chg)

$0.19 (+0.25%)
Prev Close
$75.79
Open
$75.73
Day's High
$77.14
Day's Low
$75.64
Volume
1,006,147
Avg. Vol
790,522
52-wk High
$81.13
52-wk Low
$66.83

Search Stocks

Latest Key Developments (Source: Significant Developments)

Danaher Corp gives FY 2014 revenue guidance - Conference Call
Wednesday, 15 Jan 2014 04:30pm EST 

Danaher Corp:Expects $20 bln in terms of revenue for FY 2014.FY 2014 revenue of $20.1 bln - Thomson Reuters I/B/E/S.  Full Article

Danaher Corp reaffirms FY, Q4 2013 EPS guidance; gives FY 2014 guidance; EPS guidance below analysts' estimates
Thursday, 12 Dec 2013 06:00am EST 

Danaher Corp:Reaffirms FY 2013 adjusted diluted net earnings per share (EPS) guidance of $3.37 to $3.42.Reaffirms Q4 2013 adjusted diluted net EPS guidance of $0.91 to $0.96.Sees FY 2014 GAAP diluted net EPS to be in the range of $3.60 to $3.75.Says FY 2014 EPS guidance assumes FY 2014 core revenue growth of between 2 pct and 4 pct.FY 2013 EPS $3.41 - Thomson Reuters I/B/E/S Estimates.Q4 2013 EPS $0.95 - Thomson Reuters I/B/E/S Estimates.FY 2014 EPS $3.81, revenue $20.08 bln - Thomson Reuters I/B/E/S Estimates.  Full Article

Danaher Corp announces quarterly dividend
Tuesday, 10 Dec 2013 05:25pm EST 

Danaher Corp:Says its board of directors has approved a regular quarterly dividend of $0.025 per share payable on Jan. 31, 2014 to holders of record on Dec. 30.  Full Article

Danaher Corp, Blackstone Group LP Team Up To Bid For Johnson & Johnson's Diagnostics Unit-Reuters
Thursday, 7 Nov 2013 05:33pm EST 

Reuters reported that Danaher Corp has teamed up with Blackstone Group LP to bid for Johnson & Johnson's diagnostics unit, which makes blood screening equipment and laboratory blood tests and could fetch more than $4 billion. Blackstone, declined to comment. Representatives for J&J, Danaher did not immediately respond to requests for comment.  Full Article

Danaher Corp Issues Q4 2013 EPS Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EPS Guidance
Thursday, 17 Oct 2013 06:00am EDT 

Danaher Corp announced that for fourth quarter of 2013, it expects GAAP diluted net earnings per share to be in the range of $0.91 to $0.96. The Company reaffirmed fiscal 2013 adjusted diluted net earnings per share guidance of $3.37 to $3.42. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $0.96 for fourth quarter of 2013 and EPS of $3.40 for fiscal 2013.  Full Article

Danaher Corp's Subsidiary Signs Cooperation Framework with Topchoice Medical Investment Inc Co
Wednesday, 16 Oct 2013 08:00pm EDT 

Topchoice Medical Investment Inc Co announced that it has signed a cooperation framework with KaVo Sybron, a subsidiary of Danaher Corp. Through the framework, the two companies will provide medical training and professional trainings in China.  Full Article

Danaher Corp Announces Quarterly Dividend
Wednesday, 11 Sep 2013 08:04am EDT 

Danaher Corp announced that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on October 25, 2013 to holders of record on September 27, 2013.  Full Article

Danaher Corp Issues Q3 2013 EPS Guidance Below Analysts' Estimates; Narrows FY 2013 EPS Guidance
Thursday, 18 Jul 2013 06:00am EDT 

Danaher Corp announced that for third quarter of 2013, it expects GAAP diluted net earnings per share (EPS) to be in the range of $0.78 to $0.83. The Company narrowed its fiscal 2013 adjusted diluted net earnings per share (EPS) guidance to $3.37-$3.42 from a previous range of $3.32-$3.47. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $0.84 for third quarter of 2013 and EPS of $3.41 for fiscal 2013.  Full Article

Danaher Corp Sees Q2 2013 EPS Guidance Slightly Above Prior Range-Conference Call
Tuesday, 9 Jul 2013 02:00pm EDT 

Danaher Corp announced that for the second quarter of 2013, it expects EPS to be slightly above guidance of $0.80 to $0.85. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $0.84 for second quarter of 2013.  Full Article

Danaher Corp Announces Quarterly Dividend
Tuesday, 7 May 2013 04:01pm EDT 

Danaher Corp announced that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on July 26, 2013 to holders of record on June 28, 2013.  Full Article

Photo

Danaher to buy Nobel Biocare for $2.2 billion

ZURICH - U.S. healthcare group Danaher Corp is to buy Nobel Biocare Holding AG for an agreed $2.2 billion to become the world's biggest player in a dental implants market benefiting from growing demand for cosmetic dentistry.

Search Stocks